YEAMAN KEVIN J 4

What Happened
Kevin J. Yeaman, President, CEO and a director of Dolby Laboratories (DLB), transferred a derivative security—an option covering 145,252 shares of Class A common stock—to a revocable family trust on February 5, 2026. The Form 4 shows a gift/transfer for no consideration (price $0.00), so the reported disposal and acquisition entries reflect the movement of the option from Yeaman personally into the trust; the transaction value is $0.

Key Details

• Transaction date: 2026-02-05; Report filed: 2026-02-09 (filed within two business days).
• Security type: Option (derivative) covering 145,252 shares of Class A common stock; reported price $0.00 (gift/transfer).
• Footnote F1: Transfer was to a revocable trust for estate planning and is exempt from Section 16(b) under Rule 16b-5.
• Footnote F2: The option covers 145,252 shares; vesting: 1/4 vests on the first anniversary of the vesting commencement date (Dec 15, 2025), then monthly over the following 36 months.
• Footnote F3: Transferred to the Kevin and Rachel Yeaman Family Trust dated May 14, 2009.
• Shares owned after transaction: not specified in the filing.

Context
This was a gift/estate-planning transfer of an option, not a purchase, sale or exercise of shares. Such transfers typically do not signal the insider’s view of the company’s prospects. Because this involved an unexercised option (a derivative), no shares were sold or acquired in the open market and no cash changed hands.